Member Info for SlowRoll

Old now but from the FT.
B!NP Paribas has joined JPMorgan in using digital tokens for short-term trading in fixed income markets as some of the world’s biggest investment banks step up efforts to modernise the $12tn market with blockchain technology.

The French bank has joined a blockchain-powered network run by its US rival, which has already attracted more than $300bn of deals since its launch in December.

The arrangement represents the first steps in efforts to use digital tokens in one of the crucial links of the global financial system.

James, I like your optimism a lot of which I share. But "they" say the war could last ten years and a fine whisky could be a better store of value.

Hope we're in good hands!!

a16z is bullish on games in the #Metaverse.

Venture capital firm Andreessen Horowitz has launched a $600 million fund dedicated to gaming startups focusing on Web3. https://t.co/W7t5jYKJBa

They've been there long enough.!!! Maybe BB could come alive again. Another jam jar of crude!!!

No drill this year and Minchin is toast/history!!!

What would be a fair price? Rule 3 says highest price in the last 4 months would be the minimum (790p) .I personally would be unhappy with any offer less than 1200p and would feel cheated out of one of my best investments. One which I am happy to hold for some years to come.

Thanks. HOPING for £4 !

Does not seem to be any sign of another bidder... or am I wrong!?

Trader Tone
"I will be a buyer of Bitcoin at the low at the end of the year. If Bitcoin continues to just struggle and go down and down and down and down and here we are in November sitting at $25,000, I’m going to take that as the bear market has ended, according to time.

Time, not price. Time because with enough time that goes by, you don’t need to go as low but with less time that goes by, you need to go lower to end that bear market. Either we need an imminent crash down into the $20,000 range, mid-$20,000 range, or we are going to give it another six months of frustration and then either way, the bear market ends.”

Researchers in Botswana and South Africa have detected new sub-lineages of the Omicron variant of the SARS-CoV-2 and are carrying out further investigations to fully understand crucial traits such as infectivity and virulence.

The identified sub-lineages variant are BA.4 and BA.5. World Health Organization (WHO) experts are working with scientists and researchers in the two countries to deepen analysis of the sub-lineages which have so far been identified in four people in Botswana and 23 in South Africa. Outside Africa, the BA.4 and the BA.5 have been confirmed in Belgium, Denmark, Germany and the United Kingdom.

Currently there is no significant epidemiological difference observed between the new sub-lineages and known sub-lineages of the Omicron variant, which include BA.1, BA.2 and BA.3 sub-lineages.

Maybe our test will still be needed. No excuse for not getting our ducks lined up!
The coronavirus pandemic is far from over, Bill Gates has warned, saying there could still be a variant which is "even more transmissive and even more fatal".

"We haven't even seen the worst of it," he said in an interview.

And fast tracking fracking. F**k planning permission!

As Sven Borho, co-manager of the £2bn Worldwide Healthcare Trust (LSE: WWH), says “we have seen the biggest bear market in 30 years in the biotechnology sector.” In the last 12 months or so, the S&P biotechnology index under-performed the S&P 500 by 64%, falling by nearly 50% to the level last seen in mid-2015.

“The healthcare sector now trades on a 20% discount to the S&P 500, the same as in the financial crisis. Every single time it has traded at such a discount has been the very best time to be invested, especially in innovation and growth.” This was not the consequence of the pandemic that we all expected.…”

Another nugget, thanks ragnarr.

As Sven Borho, co-manager of the £2bn Worldwide Healthcare Trust (LSE: WWH), says “we have seen the biggest bear market in 30 years in the biotechnology sector.” In the last 12 months or so, the S&P biotechnology index under-performed the S&P 500 by 64%, falling by nearly 50% to the level last seen in mid-2015.

“The healthcare sector now trades on a 20% discount to the S&P 500, the same as in the financial crisis. Every single time it has traded at such a discount has been the very best time to be invested, especially in innovation and growth.” This was not the consequence of the pandemic that we all expected.…”

I'd take £4 !

Yes, Prof really led us down the garden path!

Up another 8% today.

No drill this year would be inexcusable, **** up brewery etc. Management would then need a shake up. Personally I think they will have it covered and look forward to our discovery by Q4.